Dr Wenjun Sun | Vice President
JW Therapeutics

Dr Wenjun Sun, Vice President, JW Therapeutics

Wen-jun Sun is VP of business development and government affairs at JW Therapeutics, a leading clinical stage cell therapy biotech in Shanghai, China. Wenjun has over 20 years of broad leadership experiences at biopharmaceutical industry, in R&D, Manufacturing, Finance, Business development and partnership management, at MSD/Merck both in US and China.
 
Prior to joining JW Therapeutics, Wen-jun spend close to three years at the Bill & Melinda Gate Foundation, where he was a Senior Program Officer responsible for leading healthcare and vaccine related strategy, programs, and execution in global healthcare innovation including investment and collaboration programs.
 
Wen-jun obtained his MBA from Stern School of Business at New York University, MS of microbial engineering at the University of Minnesota, BS of microbiology & immunology at the University of Washington, and trained in clinical medicine at Shanghai JiaoTong University School of Medicine. 

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071